Lindsay H Burns
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$13.2MFederal grants as PI12 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
12 awards · $13.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 22, 2020 | NIH | SBIR Phase II Open-label extension of a 3-month blinded clinical trial of PTI-125 | $2.5M | — |
| Mar 6, 2020 | NIH | SBIR Phase II Increasing size of Phase 2b clinical trial to 60 patients | $375K | — |
| Dec 12, 2018 | NIH | SBIR Phase II Multiple Ascending Dose clinical trial of PTI-125, a novel AD therapeutic candidate | $2.9M | — |
| Sep 20, 2018 | NIH | SBIR Phase II Extending clinical trial in AD patients from 1 to 3 months | $375K | — |
| Sep 20, 2018 | NIH | SBIR Phase II Additional costs related to formulation, chronic tox and general development of PTI-125 | $350K | — |
| Sep 12, 2018 | NIH | SBIR Phase II Solid oral dosage form and chronic tox for PTI-125 | $2.9M | — |
| Aug 13, 2018 | NIH | SBIR Phase II Multiple Ascending Dose clinical trial of PTI-125, a novel AD therapeutic candidate | $261K | — |
| Sep 13, 2017 | NIH | SBIR Phase II Additional bioanalytical, dose analysis and DSMB costs for PTI-125 development | $142K | — |
| Sep 11, 2017 | NIH | SBIR Phase II IND, FIH study and 3-month tox for PTI-125, a novel therapeutic for Alzheimer's disease | $1.5M | — |
| May 31, 2017 | NIH | SBIR Phase II IND, FIH study and 3-month tox for PTI-125, a novel therapeutic for Alzheimer's disease | $225K | — |
| Jan 8, 2016 | NIH | SBIR Phase II IND- and NDA-enabling toxicology studies for PTI-125, a novel small molecule for Alzheimer's disease | $1.5M | — |
| Jul 29, 2015 | NIH | SBIR Phase II IND- and NDA-enabling toxicology studies for PTI-125, a novel small molecule for Alzheimer's disease | $225K | — |
Peer ranks
Federal funding#9
Awards as PI#36
Patents#27
Companies
No tracked company linked yet.
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.